BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 3111583)

  • 1. Effect of antihypertensive treatment on kidney function in diabetic nephropathy.
    Parving HH; Andersen AR; Smidt UM; Hommel E; Mathiesen ER; Svendsen PA
    Br Med J (Clin Res Ed); 1987 Jun; 294(6585):1443-7. PubMed ID: 3111583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effective antihypertensive treatment postpones renal insufficiency in diabetic nephropathy.
    Parving HH; Smidt UM; Hommel E; Mathiesen ER; Rossing P; Nielsen F; Gall MA
    Am J Kidney Dis; 1993 Jul; 22(1):188-95. PubMed ID: 8322782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early aggressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy.
    Parving HH; Andersen AR; Smidt UM; Svendsen PA
    Lancet; 1983 May; 1(8335):1175-9. PubMed ID: 6133986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of long-term antihypertensive treatment on kidney function in diabetic nephropathy.
    Parving HH; Andersen AR; Hommel E; Smidt U
    Hypertension; 1985; 7(6 Pt 2):II114-7. PubMed ID: 4077229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetic nephropathy and arterial hypertension. The effect of antihypertensive treatment.
    Parving HH; Andersen AR; Smidt UM; Christiansen JS; Oxenbøll B; Svendsen PA
    Diabetes; 1983 May; 32 Suppl 2():83-7. PubMed ID: 6400672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection of kidney function and decrease in albuminuria by captopril in insulin dependent diabetics with nephropathy.
    Parving HH; Hommel E; Smidt UM
    BMJ; 1988 Oct; 297(6656):1086-91. PubMed ID: 3143437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction in albuminuria predicts a beneficial effect on diminishing the progression of human diabetic nephropathy during antihypertensive treatment.
    Rossing P; Hommel E; Smidt UM; Parving HH
    Diabetologia; 1994 May; 37(5):511-6. PubMed ID: 8056190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of captopril on blood pressure and kidney function in normotensive insulin dependent diabetics with nephropathy.
    Parving HH; Hommel E; Damkjaer Nielsen M; Giese J
    BMJ; 1989 Aug; 299(6698):533-6. PubMed ID: 2507061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Remission and regression in the nephropathy of type 1 diabetes when blood pressure is controlled aggressively.
    Hovind P; Rossing P; Tarnow L; Smidt UM; Parving HH
    Kidney Int; 2001 Jul; 60(1):277-83. PubMed ID: 11422762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term effect of lisinopril and atenolol on kidney function in hypertensive NIDDM subjects with diabetic nephropathy.
    Nielsen FS; Rossing P; Gall MA; Skøtt P; Smidt UM; Parving HH
    Diabetes; 1997 Jul; 46(7):1182-8. PubMed ID: 9200654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of antihypertensive treatment on kidney function in insulin-dependent (type I) diabetics with renal failure.
    Zander E; Conde N; Heinke P; Zander G; Strese J; Gums G; Schulz B
    Exp Clin Endocrinol; 1990 Feb; 95(1):70-6. PubMed ID: 2335182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-protein diet and kidney function in insulin-dependent diabetic patients with diabetic nephropathy.
    Hansen HP; Christensen PK; Tauber-Lassen E; Klausen A; Jensen BR; Parving HH
    Kidney Int; 1999 Feb; 55(2):621-8. PubMed ID: 9987086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High blood pressure is a major factor in progression of diabetic nephropathy.
    Parving HH; Hommel E
    J Diabet Complications; 1988; 2(2):92-5. PubMed ID: 2971078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of beta-blockade and angiotensin converting enzyme inhibition on kidney function in diabetic nephropathy.
    Hommel E
    J Hypertens Suppl; 1989 Sep; 7(7):S49-51. PubMed ID: 2575661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term antihypertensive treatment inhibiting progression of diabetic nephropathy.
    Mogensen CE
    Br Med J (Clin Res Ed); 1982 Sep; 285(6343):685-8. PubMed ID: 6809187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin-converting enzyme inhibition in diabetic nephropathy: ten years' experience.
    Parving HH; Rossing P; Hommel E; Smidt UM
    Am J Kidney Dis; 1995 Jul; 26(1):99-107. PubMed ID: 7611276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The course of kidney function in type 2 (non-insulin-dependent) diabetic patients with diabetic nephropathy.
    Gall MA; Nielsen FS; Smidt UM; Parving HH
    Diabetologia; 1993 Oct; 36(10):1071-8. PubMed ID: 8243857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired autoregulation of glomerular filtration rate in type 1 (insulin-dependent) diabetic patients with nephropathy.
    Parving HH; Kastrup H; Smidt UM; Andersen AR; Feldt-Rasmussen B; Christiansen JS
    Diabetologia; 1984 Dec; 27(6):547-52. PubMed ID: 6442240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antihypertensive treatment and resistant hypertension in patients with type 1 diabetes by stages of diabetic nephropathy.
    Lithovius R; Harjutsalo V; Forsblom C; Saraheimo M; Groop PH;
    Diabetes Care; 2014; 37(3):709-17. PubMed ID: 24170765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced albuminuria during early and aggressive antihypertensive treatment of insulin-dependent diabetic patients with diabetic nephropathy.
    Parving HH; Andersen AR; Smidt UM; Friisberg B; Svendsen PA
    Diabetes Care; 1981; 4(4):459-63. PubMed ID: 7049630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.